Abstract
The concept that foreign amines incorporated into the stores which normally hold the physiological transmitter, noradrenaline, may be released as false transmitters was created less than a decade ago. Nevertheless, this idea has aroused great interest and several review articles dealing with various aspects of the subject were previously published (Sourkes, 1965; Muscholl, 1966a; Stone and Porter, 1967; Kopin, 1968a, 1968b; Thoenen, 1969). However, there are recent developments in this field which will be treated below in more detail. These include stereochemical requirements for formation of false transmitters, release of false transmitters by various stimuli, and the quantitative aspects of simultaneous release of a false transmitter and noradrenaline and their actions on adrenoceptors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Almgren, O., Anden, N.-E., Waldeck, B.: Extraneuronal binding as a possible factor of tyramine uptake by sympathetic nerves. Life Sci. 4, 121–126 (1965).
Almgren, O., Anden, N.-E., Waldeck, B., Lundborg, P.G., Stitzel, R.E.: Release of 3H-metaraminol from subcellular fractions of rat salivary glands by nerve stimulation. Europ. J. Pharmacol. 6, 109–114 (1969).
Almgren, O., Anden, N.-E., Waldeck, B., Lundborg, P.G., Stitzel, R.E., Waldeck, B.: On the disposition of (3H) metaraminol in the rat salivary gland. J. Pharm. Pharmacol. 19, 705–708 (1967).
Amery, A., Moerman, E.J., Bossaert, H., De Schaepdryver, A.F.:α-Methyl-p-tyrosine inmalignant pheochromocytoma. Pharmacol. Clin. 1, 174–176 (1969).
Anden, N.-E.: On the mechanism of noradrenaline depletion by α-methyl metatyrosine and metaraminol. Acta physiol. scand. 21, 260–271 (1964a).
Anden, N.-E.: Uptake and release of dextro-and levoadrenaline in noradrenergic stores. Acta pharmacol. (Kbh.) 21, 59–75 (1964b).
Anden, N.-E., Fuxe, K., Henning, M.: Mechanisms of noradrenaline and 5-hydroxytryptamine disappearance induced by α-methyldopa and α-methyl-metatyrosine. Europ. J. Pharmacol. 8, 302–309 (1969).
Anden, N.-E., Fuxe, K., Henning, M., Hokfelt, T.: Effect of some drugs on central monoamine nerve terminals lackingnerve impulse flow. Europ. J. Pharmacol. 1, 226–232 (1967).
Anden, N.-E., Fuxe, K., Henning, M., Hokfelt, T., Magnusson, T.: Functional significance of noradrenaline depletion by α-methyl metatyrosine, metaraminol and dextro-adrenaline. In: Pharmacology of Cholinergic and Adrenergic Transmission. Eds. Koelle, G.B., Douglas, W.W., Carlsson, A. 319–328. Oxford: Pergamon Press 1965.
Axelrod, J.: Methylation reactions in the formation and metabolism of catecholamines andother biogenic amines. Pharmacol. Rev. 18, 95–113 (1966).
Berti, F., Shore, P.A.: A kinetic analysis of drugs that inhibit the adrenergic neuronal membrane amine pump. Biochem. Pharmacol. 16, 2091–2094 (1967a).
Berti, F., Shore, P.A.: Interaction of reserpine and ouabain on amine concentrating mechanisms in theadrenergic neurone. Biochem. Pharmacol. 16, 2271–2274 (1967b).
Bhagat, B., Ragland, R.: Effect of infusion of metaraminol on the response of reserpine-pretreated spinal cats to tyramine and to noradrenaline. Brit. J. Pharmacol. 27, 506–513 (1966).
Blaschko, H.: Substrate specificity of amino-acid decarboxylases. Biochim. biophys. Acta (Amst.) 4, 130–137 (1950).
Blaschko, H., Burn, J.H., Langemann, H.: The formation of noradrenaline from dihydroxyphenyl-serine. Brit. J. Pharmacol. 5, 431–437 (1950).
Blaschko, H., Burn, J.H., Langemann, H., Richter, D., Schlossmann, H.: The oxidation of adrenaline and other amines. Biochem. J. 31, 2187–2196 (1937).
Boullin, D.J.: A calcium requirement for release of 3H-guanethidine by sympathetic nervestimulation. J. Pharm. Pharmacol. 18, 709–712 (1966).
Brunner, H., Hedwall, P.R., Maitre, L., Meier, M.: Antihypertensive effects of alpha-methylated catecholamine analogues in the rat. Brit. J. Pharmacol. 30, 108–122 (1967).
Buhs, R.P., Beck, J.L., Speth, O.C., Smith, J.L., Trenner, N.R., Cannon, P. J., Laragh, J.H.: The metabolism of methyldopa in hypertensive human subjects. J. Pharmacol, exp. Ther. 143, 205–214 (1964).
Burgen, A.S.V., Iversen, L.L.: The inhibition of noradrenaline uptake by sympathomimetic amines in the rat isolated heart. Brit. J. Pharmacol. 25, 34–49 (1965).
Cahn, R.S., Ingold, O.K., Prelog, V.: The specification of asymmetric configuration in organic chemistry. Experientia (Basel) 12, 81–94 (1956).
Carlsson, A.: Functional significance of drug-induced changes in brain monoamine levels. Progr. Brain Res. 8, 9–27 (1964).
Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.A.: Failure of reserpine to deplete noradrenaline neurons of α-methylnoradrenaline formed from α-methyl DOPA. Acta pharmacol. (Kbh.) 22, 270–276 (1965a).
Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.A., Hillarp, N.A., Waldeck, B.: Analysis of the Mg++-ATP dependent storage mechanism in the amine granules of the adrenal medulla. Acta physiol. scand. 59, Suppl. 215 (1963).
Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.A., Hillarp, N.A., Waldeck, B., Lindqyist, M.: In-vivo decarboxylation of α-methyl dopa and α-methyl metatyrosine. Acta physiol. scand. 54, 87–94 (1962).
Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.A., Hillarp, N.A., Waldeck, B., Lindqyist, M., Dahlström, A., Fuxe, K., Masxjoka, D.: Effects of the amphetamine group on intra-neuronal brain amines in vivo and in vitro. J. Pharm. Pharmacol. 17, 521–524 (1965b).
Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.A., Hillarp, N.A., Waldeck, B., Lindqyist, M., Dahlström, A., Fuxe, K., Masxjoka, D., Lundborg, P., Stitzel, R., Waldeck, B.: Uptake, storage and release of 3H-a-methyl-norepinephrine. J. Pharmacol, exp. Ther. 158, 175–182 (1967).
Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.A., Hillarp, N.A., Waldeck, B., Lindqyist, M., Dahlström, A., Fuxe, K., Masxjoka, D., Lundborg, P., Stitzel, R., Waldeck, B., Meisch, J.-J., Waldeck, B.: On the /Miydroxylation of (±)-a-methyldopamine in vivo. Europ. J. Pharmacol. 5, 85–92 (1968).
Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.A., Hillarp, N.A., Waldeck, B., Lindqyist, M., Dahlström, A., Fuxe, K., Masxjoka, D., Lundborg, P., Stitzel, R., Waldeck, B., Meisch, J.-J., Waldeck, B., Waldeck, B.: ß-Hydroxylation of tyramine in vivo. Acta pharmacol. (Kbh.) 20, 371–374 (1963).
Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.A., Hillarp, N.A., Waldeck, B., Lindqyist, M., Dahlström, A., Fuxe, K., Masxjoka, D., Lundborg, P., Stitzel, R., Waldeck, B., Meisch, J.-J., Waldeck, B., Waldeck, B.: Inhibition of 3H-metaraminol uptake by antidepressive and related drugs. J. Pharm.Pharmacol. 17, 243–244 (1965a).
Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.A., Hillarp, N.A., Waldeck, B., Lindqyist, M., Dahlström, A., Fuxe, K., Masxjoka, D., Lundborg, P., Stitzel, R., Waldeck, B., Meisch, J.-J., Waldeck, B., Waldeck, B.: Rapid release of 3H-metaraminol induced by combined treatment with protriptyline andreserpine. J. Pharm. Pharmacol. 17, 327–328 (1965b).
Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.A., Hillarp, N.A., Waldeck, B., Lindqyist, M..: Mechanism of amine transport in the cell membranes of the adrenergic nerves. ActaPharmacol. (Kbh.) 22, 293–300 (1965c).
Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.A., Hillarp, N.A., Waldeck, B., Lindqyist, M., Dahlström, A., Fuxe, K., Masxjoka, D., Lundborg, P., Stitzel, R., Waldeck, B., Meisch, J.-J., Waldeck, B., Waldeck, B.: Release of 3H-metaraminol by different mechanisms. Acta physiol. scand. 67, 471–480 (1966a).
Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.A., Hillarp, N.A., Waldeck, B., Lindqyist, M., Dahlström, A., Fuxe, K., Masxjoka, D., Lundborg, P., Stitzel, R., Waldeck, B., Meisch, J.-J., Waldeck, B., Waldeck, B.: Structure-activity relationships for release of 14C-octopamine from adrenergic nervesby phenethylamines. Acta pharmacol. (Kbh.) 24, 255–262 (1966b).
Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.A., Hillarp, N.A., Waldeck, B., Lindqyist, M., Dahlström, A., Fuxe, K., Masxjoka, D., Lundborg, P., Stitzel, R., Waldeck, B., Meisch, J.-J., Waldeck, B., Waldeck, B.: Different mechanisms of drug-induced release of noradrenaline and its congenersa-methyl-noradrenaline and metaraminol. Europ. J. Pharmacol. 4, 165–168 (1968).
Chidsey, C.A., Harrison, D.C.: Studies on the distribution of exogenous norepinephrine in the sympathetic transmitter store. J. Pharmacol, exp. Ther. 140, 217–223 (1963).
Chidsey, C.A., Harrison, D.C., Kaiser, G.A., Lehr, B.: The hydroxylation of tyramine in the isolated canine heart. J. Pharmacol, exp. Ther. 144, 393–398 (1964).
Conradi, E.C., Gaffney, T.E., Fink, D.A., Vangrow, J.S.: Reversal of sympathetic nerve blockade: A comparison of dopa, dopamine, and norepinephrine with their α-methylated analogues. J. Pharmacol, exp. Ther. 150, 26–33 (1965).
Costa, E., Neff, N.H., Ngai, S.H.: Regulation of metaraminol efflux from rat heart and salivary glands. Brit. J. Pharmacol. 36, 153–160 (1969).
Creveling, C.R.: Drugs interfering with the formation of adrenergic transmitters. In: Pharmacology of Cholinergic and Adrenergic Transmission. Eds. Koelle, G.B., Douglas, W.W., Carlsson, A. 185–204. Oxford: Pergamon Press 1965.
Crout, J.R., Alpers, H.S., Tatum, E.L., Shore, P.A.: Release of metaraminol (aramine) from the heart by sympathetic nerve stimulation. Science 145, 828–829 (1964).
Crout, J.R., Alpers, H.S., Tatum, E.L., Shore, P.A., Shore, P.A.: Differential release of metaraminol and norepinephrine from the cat heart. Pharmacologist 6, 175 (1964).
Davies, B.N., Horton, E.W., Withrington, P.G.: The occurrence of prostaglandin E2 in splenic venous blood of the dog following splenic nerve stimulation. J. Physiol. (Lond.) 188, 38P–39P (1967).
Day, M.D., Rand, M.J.: A hypothesis for the mode of action of α-methyldopa in relieving hypertension. J. Pharm. Pharmacol. 15, 221–224 (1963).
Day, M.D., Rand, M.J.: Some observations on the pharmacology of α-methyldopa. Brit. J. Pharmacol. 22, 72–86 (1964).
Drews, E.-F., Lindmar, R., Muscholl, E.: Noradrenaline depleting and blood pressure lowering activity of threo-corbadrine. Europ. J. Pharmacol. 3, 167–169 (1968).
Farrugia, M.T., Hunter, W.H., Kirk, G.: The preparation and pharmacological properties of !F-corbasil. J. Pharm. Pharmacol. 21, Suppl. 199S–205S (1969).
Fein, J., Holtz, P., Palm, D.: Beeinflussung des Nervenreizes und der Noradrenalinwirkung am isolierten Hypogastricus-Vas deferens-Präparat des Meerschweinchens durch α-Methyl-dopamin und andere α-methylierte sympathicomimetische Amine. Naunyn-Schmiede-berg’s Arch. Pharmak. exp. Path. 258, 334–351 (1967).
Fischer, J.E., Horst, W.D., Kopin, I. J.: ß-Hydroxylated sympathomimetic amines as false neurotransmitters. Brit. J. Pharmacol. 24, 477–484 (1965).
Fischer, J.E., Horst, W.D., Kopin, I. J., Weise, V.K., Kopin, I.J.: Release of tritiated bretylium by sympathetic nerve stimula-tion. Nature (Lond.) 209, 778–779 (1966).
Furchgott, R.F., Kirpekar, S.M., Rieker, M., Schwab, A.: Actions and interactions of norepinephrine, tyramine and cocaine on aortic strips of rabbit and left atria of guinea pig and cat. J. Pharmacol, exp. Ther. 142, 39–58 (1963).
Furchgott, R.F., Kirpekar, S.M., Rieker, M., Schwab, A., Sanchez Garcia, P.: Effects of inhibition of monoamine oxidase on the actions and inter-actions of norepinephrine, tyramine and other drugs on guinea-pig left atrium. J. Pharmacol. exp. Ther. 163, 98–122 (1968).
Gessa, G.L., Costa, E., Kuntzman, R., Brodie, B.B.: On the mechanism of norepinephrine release by α-methyl-metatyrosine. Life Sci. 1, 353–360 (1962).
Giachetti, A., Shore, P.A.: Studies in vitro of amine uptake mechanisms in heart. Biochem. Pharmacol. 15, 607–614 (1966).
Gillespie, L., Oates, J.A., Crout, J.R., Sjoerdsma, A.: Clinical and chemical studies with α-methyl-dopa in patients with hypertension. Circulation 25, 281–291 (1962).
Gjessing, L.R.: Studies on urinary phenolic compounds in man. II. Phenolic-acids and-amines during a load of α-methyl-dopa and disulfiram in periodic catatonia. Scand. J. clin. Lab. Invest. 17, 549–557 (1965).
Goldberg, L.I., Da Costa, F.M., Ozaki, M.: Actions of the decarboxylase inhibitor, α-methyl–3, 4-dihydroxyphenylalanine, in the dog. Nature (Lond.) 188, 502–504 (1960).
Goldstein, M., Anagnoste, B.: The conversion in vivo of D-amphetamine to (-[-ß-hydroxy-norephedrine. Biochim. biophys. Acta (Amst.) 107, 166–168 (1965).
Goldstein, M., Anagnoste, B., Mckereghan, M.R., Lauber, E.: The stereospecificity of the enzymatic amphetamine ß-hydroxylation. Biochim. biophys. Acta (Amst.) 89, 191–193 (1964).
Gram, T.E., Wright, H.N.: Lack of metaraminol biotransformation by rabbit tissues in vitro. Biochem. Pharmacol. 14, 1911–1914 (1965).
Gram, T.E., Wright, H.N.: Some factors influencing the action of metaraminol in rabbits. Arch. int. Pharmacodyn. 160, 294–311 (1966).
Grobecker, H., Holtz, P.: Über die Brenzkatechinamine im Froschherzen und in der Froschhaut vor und nach Verabfolgung von α-Methyldopa. Experientia (Basel) 22, 42–43 (1966).
Grobecker, H., Holtz, P., Müller, H.K.: Die Wirkung von α-Methyldopa und Dopa auf den Brenzcatechin-amingehalt des Herzens, der Nebennieren und der Haut des Frosches sowie auf die Melanophoren der Froschhaut. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 255, 474–490 (1966).
Haefely, W., Hürlimann, A., Thoenen, H.: The effect of stimulation of sympathetic nerves in the cat treated with reserpine, α-methyldopa and α-methylmetatyrosine. Brit. J. Pharmacol. 26, 172–185 (1966).
Haefely, W., Hürlimann, A., Thoenen, H.: Adrenergic transmitter changes and response to sympathetic nerve stimulationafter differing pretreatment with α-methyldopa. Brit. J. Pharmacol. 31, 105–119 (1967).
Häggendal, J., Malmfors, T.: The effect of nerve stimulation on catecholamines taken up in adrenergic nerves after reserpine pretreatment. Acta physiol. scand. 75, 33–38 (1969).
Hamberger, B.: Reserpine-resistant uptake of catecholamines in isolated tissues of the rat. Acta physiol. scand. 71, Suppl. 295 (1967).
Hamberger, B., Malmfors, T., Norberg, K.-A., Sachs, C.: Uptake and accumulation of catecholamines in peripheral adrenergic neurons of reserpinized animals, studied with a histochemical method. Biochem. Pharmacol. 13, 841–844 (1964).
Henning, M.: Studies on the mode of action of α-methyldopa. Acta physiol. scand. Suppl. 322 (1969).
Henning, M., Svensson, L.: Adrenergic nerve function in the anaesthetized rat after treatment with α-methyldopa. Acta pharmacol. (Kbh.) 26, 425–436 (1968).
Hertting, G., Potter, L.T., Axelrod, J.: Effect of decentralization and ganglionic blocking agents on the spontaneous release of 3H-norepinephrine. J. Pharmacol, exp. Ther. 136, 289–292 (1962).
Hess, S.M., Connamacher, R.H., Ozaki, M., Udenfriend, S.: The effects of α-methyl-dopa and α-methyl-metatyrosine on the metabolism of norepinephrine and serotonin in vivo. J. Pharmacol, exp. Ther. 134, 129–138 (1961).
Holtz, P., Heise, R., Lüdtke, K.: Fermentativer Abbau von 1-Dioxyphenylalanin (Dopa) durch Niere. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 191, 87–118 (1938).
Holtz, P., Heise, R., Lüdtke, K., Palm, D.: Brenzkatechinamine und andere sympathicomimetische Amine. Biosynthese und Inaktivierung, Freisetzung und Wirkung. Ergebn. Physiol. 58, 1–580. Berlin-Heidelberg-New York: Springer 1966.
Holtz, P., Heise, R., Lüdtke, K., Palm, D.: On the pharmacology of α-methylated catecholamines and the mechanism of the anti-hypertensive action of α-methyldopa. Life Sci. 6, 1847–1857 (1967).
Hukovtö, S., Muscholl, E.: Die Noradrenalin-Abgabe aus dem isolierten Kaninchenherzen bei sympathischer Nervenreizung und ihre pharmakologische Beeinflussung. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 244, 81–96 (1962).
Ikeda, M., Levitt, M., Udenfriend, S.: Hydroxylation of phenylalanine by purified preparations of adrenal and brain tyrosine hydroxylase. Biochem. biophys. Res. Commun. 18, 482–488 (1965).
Iversen, L. L.: The Uptake and Storage of Noradrenaline in Sympathetic Nerves. Cambridge: University Press 1967.
Iversen, L. L., Glowinski, J., Axelrod, J.: The uptake and storage of 3H-norepinephrine in the reser-pine-pretreated rat heart. J. Pharmacol, exp. Ther. 150, 173–183 (1965).
Iversen, L. L., Glowinski, J., Axelrod, J.: The physiologic disposition and metabolism of norepinephrine in immunosym-pathectomized animals. J. Pharmacol, exp. Ther. 151, 273–284 (1966).
Johnson, G.E., Mickle, D.: The influence of cold exposure on the in vivo release of metaraminol. Brit. J. Pharmacol. 28, 246–254 (1966).
Johnson, G.E., Mickle, D., Pugsley, T.A.: The formation and release of metaraminol during exposure to warm or cold environments. Brit. J. Pharmacol. 34, 267–276 (1968).
Johnson, G.E., Mickle, D., Pugsley, T.A.: Studies on the interrelationship between the syntheses of noradrenaline and metar-aminol. Brit. J. Pharmacol. 39, 167–174 (1970).
Johnson, G.E., Mickle, D., Pugsley, T.A., Ritzen, M.: Microspectrofluorometric identification of metaraminol in sympathetic adrenergic neurons. Acta physiol. scand. 67, 505–513 (1966).
Juorio, A. V., Vogt, M.: Monoamines and their metabolites in the avian brain. J. Physiol. (Lond.) 189, 489–518 (1967).
Kakimoto, Y., Armstrong, M.D.: On the identification of octopamine in mammals. J. biol. Chem. 237, 422–427 (1962).
Kilbinger, H., Lindmar, R., Löffelholz, K., Muscholl, E., Patil, P.N.: Storage and release of false transmitters after infusion of (+)-and (-)-a-methyldopamine. Naunyn-Schmiedeberg’s Arch. Pharmak. 271, 234–248 (1971).
Kisin, I.E.: Der Einfluß von Reserpin, α-Methyldopa und Bretylium auf die Erregungsübertragung von den sympathischen Nerven auf die Gefäße. Verh. dtsch. Ges. exper. Med. 19, 228–236 (1967).
Kopin, I.J.: Biochemical aspects of release of norepinephrine and other amines from sympathetic nerve endings. Pharmacol. Rev. 18, 513–523 (1966).
Kopin, I.J.: False adrenergic transmitters. Ann. Rev. Pharmacol. 8, 377–394 (1968a).
Kopin, I.J.: The influence of false adrenergic transmitters on adrenergic neurotransmission. In: Adrenergic Neurotransmission. Eds. Wolstenholme, G.E.W., O’Connor, M. 95–104. London: Churchill 1968b.
Kopin, I.J., Fischer, J.E., Musacchio, J.M., Horst, W.D., Weise, V.K.: “False neurochemical transmitters” and the mechanism of sympathetic blockade by monoamine oxidase inhibitors. J. Pharmacol, exp. Ther. 147, 186–193 (1965).
Kopin, I.J., Fischer, J.E., Musacchio, J.M., Horst, W.D., Weise, V.K., Weise, V. K.: Effect of reserpine and metaraminol on excretion of homovanillic acid and 3-methoxy–4-hydroxyphenylglycol in the rat. Biochem. Pharmacol. 17, 1461–1464 (1968).
Kopin, I.J., Fischer, J.E., Musacchio, J.M., Horst, W.D., Weise, V.K., Weise, V. K., Sedvall, G. C.: Effect of false transmitters on norepinephrine synthesis. J. Pharmacol.exp. Ther. 170, 246–252 (1969).
Korol, B., Soffer, L., Brown, M.L.: Some cardiovascular studies on octopamine. Arch. int. Pharmacodyn. 171, 415–424 (1968).
Krauss, K.R., Kopin, I. J., Weise, V.K.: The effect of bretylium on amine retention in rat heart. J. Pharmacol, exp. Ther. 172, 282–288 (1970).
Kroneberg, G., Stoepel, K.: Der Einfluß von α-Methyl-Dopa auf die Tyraminwirkung an mit Reserpin vorbehandelten Katzen. Experientia (Basel) 19, 252–253 (1963).
Lee, F.-L., Weiner, N., Trendelenburg, U.: The uptake of tyramine and formation of octopamine in normal and tachyphylactic rat atria. J. Pharmacol, exp. Ther. 155, 211–222 (1967).
Levine, R.J., Sjoerdsma, A.: Dissociation of the decarboxylase-inhibiting and norepinephrine-depleting effects of α-methyl-dopa, α-ethyl-dopa, 4-bromo–3-hydroxy-benzyloxy-amine and related substances. J. Pharmacol, exp. Ther. 146, 42–47 (1964).
Lewander, T.: Displacement of brain and heart noradrenaline by p-hydroxynorephedrine after administration of p-hydroxyamphetamine. Acta pharmacol. (Kbh.) 29, 20–32 (1971a).
Lewander, T.: On the presence of p-hydroxynorephedrine in the rat brain and heart in relation to changes in catecholamine levels after administration of amphetamine. Acta pharmacol. (Kbh.) 29, 33–48 (1971b).
Lindmar, R., Muscholl, E.: Die Wirkung von Pharmaka auf die Elimination von Noradrenalin aus der Perfusionsflüssigkeit und die Noradrenalinaufnahme in das isolierte Herz. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 247, 469–492 (1964).
Lindmar, R., Muscholl, E.: Die Aufnahme von α-Methylnoradrenalin in das isolierte Kaninchenherz und seineFreisetzung durch Reserpin und Guanethidin in vivo. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 249, 529–548 (1965).
Lindmar, E., Muscholl, E., Rahn, K.H.: Effects of rest and physical activity on the urinary excretion of noradrenaline and α-methylnoradrenaline in human subjects treated with α-methyldopa. Europ. J. Pharmacol. 2, 317–319 (1968).
Lindmar, E., Muscholl, E., Rahn, K.H., Sprenger, E.: Funktionelle Bedeutung der Freisetzung von Dihydroxyephedrin und Dihydroxypseudoephedrin als „falschen” sympathischen tlbertragerstoffen am Herzen. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 256, 1–25 (1967).
Lovenberg, W., Weissbach, H., Udenfriend, S.: Aromatic L-amino-acid decarboxylase. J. biol. Chem. 237, 89–93 (1962).
Lundborg, P., Stitzel, R.: Uptake of biogenic amines by two different mechanisms present in adrenergic granules. Brit. J. Pharmacol. 29, 342–349 (1967a).
Lundborg, P., Stitzel, R.: Effect of reserpine and protriptyline on the subcellular distribution of 3H-metaraminolin the mouse heart. Brit. J. Pharmacol. 30, 379–384 (1967b).
Lundborg, P., Stitzel, R.: Stereospecificity and intracellular binding of metaraminol. Acta physiol. scand. 72, 392–395 (1968a).
Lundborg, P., Stitzel, R.: Studies on the relationship between adrenergic nerve function and granular uptakemechanisms. Brit. J. Pharmacol. 33, 98–104 (1968b).
Maier, R., Maitre, L., Staehelin, M.: Tyramine induced lipolysis following pretreatment of guinea pigs and rats with metaraminol. Biochem. Pharmacol. 16, 1509–1515 (1967).
Maitre, L.: Presence of α-methyl-Dopa metabolites in heart and brain of guinea pigs treated with α-methyl-tyrosine. Life Sci. 4, 2249–2256 (1965).
Maitre, L., Staehelin, M.: Effect of α-methyl-DOPA on myocardial catecholamines. Experientia (Basel) 19, 573–575 (1963).
Maitre, L., Staehelin, M.: Presence of α-methyl-noradrenaline fcorbasil’) in the heart of guinea pigs treated withmetaraminol (“Aramine”). Nature (Lond.) 206, 723–724 (1965).
Maitre, L., Staehelin, M.: On the norepinephrine replacement by α-methyl-norepinephrine in the rat heart aftertreatment with α-methyl-DOPA. Experientia (Basel) 23, 810–811 (1967).
Malik, K.U.: Effect of (±) dihydroxy ephedrine and (±) dihydroxy pseudoephedrine on adrenergic transmission in mesenteric arteries. Brit. J. Pharmacol. 41, 352–360 (1971).
Malik, K.U, Muscholl, E.: The effect of α-methyldopa on the vasoconstrictor responses of the rat mesenteric artery preparation to nerve stimulation. Arzneimittel-Forsch. (Drug Res.) 19, 1111–1113 (1969a).
Malik, K.U.: Effect Of Sympathomimetic Amines On The Response Of The Perfused Mesenteric Artery Preparation To Adrenergic Nerve Stimulation. Arzneimittel-Forsch. (Drug Res.) 19, 1574 To 1579 (1969B).
Malmfors, T.: Studies on adrenergic nerves. The use of rat and mouse iris for direct observations on their physiology and pharmacology at cellular and subcellular levels. Acta physiol. scand. 64, Suppl. 248 (1965).
Masuoka, D.T., Alcaraz, A., Hanson, E.: Studies on the formation of octopamine in mice and rats. Biochim. biophys. Acta (Amst.) 86, 260–263 (1964).
Mccurdy, R.L., Prange, Jr., A.L., Lipton, M.A., Cochrane, C.M.: Effects of α-methyl-dihydroxyphenylalanine, reserpine, and dihydroxyphenylalanine on pressor responses to norepinephrine and tyramine in humans. Proc. Soc. exp. Biol. (N.Y.) 116, 1159–1163 (1964).
Mohammed, S., Gaffney, T.E., Yard, A.C., Gomez, H.: Effect of methyldopa, reserpine and guanethidine on hindleg vascular resistance. J. Pharmacol, exp. Ther. 160, 300–307 (1968).
Molinoff, P., Axelrod, J.: Octopamine: normal occurrence in sympathetic nerves of rats. Science 164, 428–429 (1969).
Molinoff, P., Axelrod, J., Landsberg, L., Axelrod, J.: An enzymatic assay for octopamine and other ß-hydroxy-lated phenethylamines. J. Pharmacol, exp. Ther. 170, 253–261 (1969).
Murad, J.E., Shore, P.A.: Association between biochemical and behavioral actions of tricyclic antidepressants. Int. J. Neuropharmacol. 5, 299–304 (1966).
Musacchio, J.M., Bhagat, B., Jackson, C.J., Kopin, I.J.: The effect of disulfiram on the restoration of the response to tyramine by dopamine and α-methyldopa in the reserpine-treated rat. J. Pharmacol, exp. Ther. 152, 293–297 (1966a).
Musacchio, J.M., Bhagat, B., Jackson, C.J., Kopin, I.J., Fischer, J.E., Kopin, I.J.: Subcellular distribution and release by sympathetic nerve stimulation of dopamine and α-methyldopamine. J. Pharmacol, exp. Ther. 152, 51–55 (1966b).
Musacchio, J.M., Bhagat, B., Jackson, C.J., Kopin, I.J., Fischer, J.E., Kopin, I.J., Goldstein, M.: Biosynthesis of norepinephrine and norsynephrine in the perfused rabbit heart. Biochem. Pharmacol. 12, 1061–1063 (1963).
Musacchio, J.M., Bhagat, B., Jackson, C.J., Kopin, I.J., Fischer, J.E., Kopin, I.J., Goldstein, M., Kopin, I. J., Weise, V.K.: Subcellular distribution of some sympathomimetic amines and their ß-hydroxylated derivatives in the rat heart. J. Pharmacol, exp. Ther. 148, 22–28 (1965a).
Musacchio, J.M., Bhagat, B., Jackson, C.J., Kopin, I.J., Fischer, J.E., Kopin, I.J., Goldstein, M., Kopin, I. J., Weise, V.K., Weise, V.K., Kopin, I.J.: Mechanism of norepinephrine binding. Nature (Lond.) 205, 606–607 (1965b).
Mxjscholl, E.: Biosynthese (aus α-Methyldopa), Aufnahme und Freisetzung von α-Methyl-adrenalin. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 251, 162–163 (1965).
Mxjscholl, E., Autonomie Nervous System: Newer mechanisms of adrenergic blockade. Ann. Rev. Pharmacol. 6, 107–128 (1966a).
Mxjscholl, E., Autonomie Nervous System, Release Of Catecholamines From The Heart. In: Mechanisms of Release of Biogenic Amines. Eds. Euler, U.S. Von, Rosell, S., Uvnäs, B. 247–260. Oxford: Pergamon Press 1966b.
Mxjscholl, E., Autonomie Nervous System, Release Of Catecholamines From The Heart. In: Drews, E.-F., Lindmar, R.: Aufnahme von threo-Corbadrin und seine Freisetzung als falsche sympathische Überträgersubstanz. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 260, 180–181 (1968).
Mxjscholl, E.:, Autonomie Nervous System, Release Of Catecholamines From The Heart. In, Lindmar, R.: Wirkungen von threo-1-(3, 4-Dihydroxyphenyl)-1-hydroxy-2-aminopropan, dem Diastereomeren von Corbadrin. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 257, 314–315 (1967).
Mxjscholl, E., Autonomie Nervous System, Release Of Catecholamines From The Heart. In, Lindmar, R., Maitre, L.: Release by sympathetic stimulation of α-methylnoradrenaline stored in the heart after administration of α-methyldopa. Experientia (Basel) 19, 658–659 (1963).
Mxjscholl, E., Autonomie Nervous System, Release Of Catecholamines From The Heart. In, Lindmar, R., Maitre, L., Rahn, K.H.: Nachweis von α-Methylnoradrenalin im Harn von Hypertonikern während einer Behandlung mit α-Methyldopa. Klin. Wschr. 44, 1412–1413 (1966).
Mxjscholl, E., Autonomie Nervous System, Release Of Catecholamines From The Heart. In, Lindmar, R., Maitre, L., Rahn, K.H.: Über den Nachweis und die Bedeutung von α-Methylnoradrenalin im Harn vonHypertonikern bei Verabreichung von α-Methyldopa. Pharmacol. Clin. 1, 19–29 (1968).
Mxjscholl, E., Autonomie Nervous System, Release Of Catecholamines From The Heart. In, Lindmar, R., Maitre, L., Rahn, K.H., Sprenger, E.: Vergleichende Untersuchung der Blutdruckwirkung, Aufnahme und Speicherung von Dihydroxyephedrin (a-Methyladrenalin) und Dihydroxypseudoephedrin. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 254, 109–124 (1966).
Mxjscholl, E., Autonomie Nervous System, Release Of Catecholamines From The Heart. In, Lindmar, R., Maitre, L., Rahn, K.H., Sprenger, E., Weber, E.: Die Hemmung der Aufnahme von α-Methylnoradrenalin in das Herz durch sympathomimetische Amine. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 252, 134–143 (1965).
Neef, N.H., Ngai, S.H., Wang, C.T., Costa, E.: Calculation of the rate of catecholamine synthesis from the rate of conversion of tyramine–14C to catecholamines. Effect of adrenal demedullation on synthesis rate. Molec. Pharmacol. 5, 90–99 (1969).
Oates, J.A., Gillespie, L., Udenfriend, S., Sjoerdsma, A.: Decarboxylase inhibition and blood pressure reduction by α-methyl–3, 4-dihydroxy-D, L-phenylalanine. Science 131, 1890–1891 (1960).
Palm, D., Langeneckert, W., Holtz, P.: Bedeutung der N-und α-Methylierung für die Affinität von Brenzcatechinaminen zu den adrenergischen Receptoren. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 258, 128–149 (1967).
Patil, P.N., Jacobowitz, D.: Steric aspects of adrenergic drugs. IX. Pharmacologic and histochemical studies on isomers of cobefrin (a-methylnorepinephrine). J. Pharmacol, exp. Ther. 161, 279–295 (1968).
Patil, P.N., Jacobowitz, D., Lapidus, J.B., Tye, A.: Steric aspects of adrenergic drugs. J. pharm. Sci. 59, 1205–1234 (1970).
Paton, D.M.: Cation and metabolic requirements for retention of metaraminol by rat uterine horns. Brit. J. Pharmacol. 33, 277–286 (1968).
Paton, D.M.: Effects of Na+ and K+ on the uptake of metaraminol by rabbit ventricular slices. Brit. J. Pharmacol. 41, 65–75 (1971).
Pettinger, W.A., Spector, S., Horwitz, D., Sjoerdsma, A.: Restoration of tyramine pressor responses in reserpine-treated animals by methyldopa and its amine metabolites. Proc. Soc. exp. Biol. (N.Y.) 118, 988–993 (1965).
Philippu, A., Schümann, H.J.: Effect of α-methyldopa, α-methyldopamine, and α-methyl-norepinephrine on the norepinephrine content of the isolated heart. Life Sci. 4, 2039 to 2046 (1965).
Philippu, A., Schümann, H.J.: Aufnahme von α-Methyldopamin und α-Methylnoradrenalin in die Noradrenalinspeichernden Herzgranula. Experientia (Basel) 22, 119–120 (1966).
Philippu, A., Schümann, H.J.: Bildung und Speicherung von α-Methylnoradrenalin. Naunyn-Schmiedeberg’s Arch.Pharmak. exp. Path. 256, 183–195 (1967).
Pöch, G.R., Kopin, I.J.: The rôle of octopamine in tachyphylaxis to tyramine. Biochem. Pharmacol. 15, 210–212 (1966).
Porter, C.C., Titus, D.C.: Distribution and metabolism of methyldopa in the rat. J. Pharmacol. exp. Ther. 139, 77–87 (1963).
Porter, C.C., Titus, D.C., Torchiana, M.L., Totaro, J. A., Stone, C.A.: Displacement of norepinephrine from the rat heart by 14C-metaraminol. Biochem. Pharmacol. 16, 2117–2124 (1967).
Porter, C.C., Titus, D.C., Torchiana, M.L., Totaro, J. A., Stone, C.A., Totaro, J.A., Burcin, A.: The relation between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labelled methyldopa or 6-hydroxydopamine. J. Pharmacol, exp. Ther. 150, 17–22 (1965).
Porter, C.C., Titus, D.C., Torchiana, M.L., Totaro, J. A., Stone, C.A., Totaro, J.A., Burcin, A., Leiby, C.M.: Some biochemical effects of α-methyl–3, 4-dihydr oxypheny 1 al anine andrelated compounds in mice. J. Pharmacol, exp. Ther. 134, 139–145 (1961).
Potter, L.T., Axelrod, J.: Studies on the storage of norepinephrine and the effect of drugs. J. Pharmacol, exp. Ther. 140, 199–206 (1963).
Potter, L.T., Axelrod, J., Kopin, I.J.: Differential binding and release of norepinephrine and tachyphylaxis. Biochem. Pharmacol. 11, 254–256 (1962).
Prescott, L.F., Buhs, R.P., Beattie, J.O., Speth, O.C., Trenner, N.R., Lasagna, L.: Combined clinical and metabolic study of the effects of α-methyldopa on hypertensive patients. Circulation 34, 308–321 (1966).
Pruss, T.P., Maengwyn-Davies, G.D., Wurzel, M.: Comparison of effects of aromatic sympathomimetic amines on rabbit aortic strip and rabbit blood pressure. J. Pharmacol, exp. Ther. 147, 76–85 (1965).
Rahn, K.H., Gilfrich, H.J., Olbermann, M.: Ein Vergleich der Kreislaufwirkungen von Noradrenalin und α-Methylnoradrenalin als Studie über den Wirkungsmechanismus von α-Methyldopa. Verh. dtsch. Ges. inn. Med. 76, 937–939 (1970).
Rossum, J.M., Van: The relation between chemical structure and biological activity. J. Pharm. Pharmacol. 15, 285–316 (1963).
Rossum, J.M., Van, Hurkmans, J.A.T.M.: Reversal of the effect of α-methyldopa by m.a.o. inhibitors. J. Pharm. Pharmacol. 15, 493–499 (1963).
Saart, W.S., Raab, A.W., Engelhardt, E.L.: The stereoisomers of α-(1-aminoethyl)-w-hydroxybenzyl alcohol. J. Med. Chem. 11, 1115–1117 (1968).
Salmon, G.K., Ireson, J.D.: A correlation between the hypotensive action of methyldopa and its depression of peripheral sympathetic function. Arch. int. Pharmacodyn. 183, 60–64 (1970).
Schaumann, O.: Über Oxy-Ephedrine. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 160, 127–176 (1931).
Schaumann, O.: Zur Pharmakologie der optischen Isomeren des 3, 4-Dioxy-nor-Ephedrins (Corbasil). Medizin und Chemie 3, 383–392. Leverkusen: Bayer 1936.
Schmitt, H., Petillot, N.: Influence du remplacement de la noradrenaline par des faux médiateurs et de l’inhibition de la synthèse sur l’excitabilité sympathique. J. Pharmacol. (Paris) 1, 183–194 (1970).
Schümann, H.J., Grobecker, H.: Nachweis und Lokalisation von α-Methylnoradrenalin in Meerschweinchenorganen nach Vorbehandlung mit α-Methyl-Dopa. Naunyn-Schmiede-berg’s Arch. exp. Path. Pharmak. 247, 297–298 (1964).
Schümann, H.J., Grobecker, H., Schmidt, K.: Über die Wirkung von α-Methyl-Dopa auf den Brenzcatechinamingehaltvon Meerschweinchenorganen. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 251, 48–61 (1965).
Sedvall, G.C., Weise, V.K., Kopin, I.J.: The rate of norepinephrine synthesis measured in vivo during short intervals; influence of adrenergic nerve impulse activity. J. Pharmacol, exp. Ther. 159, 274–282 (1968).
Shore, P.A., Alpers, H.S.: Fluorometric estimation of metaraminol and related compounds. Life Sci. 3, 551–554 (1964).
Shore, P.A., Alpers, H.S., Busfield, D., Alpers, H.S.: Binding and release of metaraminol: Mechanism of nor-epinephrine depletion by α-methyl-m-tyrosine and related agents. J. Pharmacol, exp. Ther. 146, 194–199 (1964).
Sjoerdsma, A., Studnitz, W., Von: Dopamines-oxidase activity in man, using hydroxy-amphetamine as substrate. Brit. J. Pharmacol. 20, 278–284 (1963).
Sjoerdsma, A., Studnitz, W., Von, Vendsalu, A., Engelman, K.: Studies on the metabolism and mechanism of action of methyldopa. Circulation 28, 492–502 (1963).
Smith, C. B.: The role of monoamine oxidase in the intraneuronal metabolism of norepine-phrine released by indirectly acting sympathomimetic amines or by adrenergic nerve stimulation. J. Pharmacol, exp. Ther. 151, 207–220 (1966).
Sogani, R.K., Sharma, V.N.: Modification of vascular actions of sympathomimetic drugs by methyldopa. Arch. int. Pharmacodyn. 159, 135–139 (1966).
Sourkes, T.L.: Inhibition of dihydroxyphenylalanine decarboxylase by derivatives of phenylalanine. Arch. Biochem. Biophys. 51, 444–456 (1954).
Sourkes, T.L.: The action of α-methyldopa in the brain. Brit. med. Bull. 21, 66–69 (1965).
Sourkes, T.L., Murphy, G.F., Chavez, B., Zielinska, M.: The action of some α-methyl and other amino acids on cerebral catecholamines. J. Neurochem. 8, 109–115 (1961).
Spector, S., Gordon, R., Sjoerdsma, A., Udenfriend, S.: End-product inhibition of tyrosine hydroxylase as a possible mechanism for regulation of norepinephrine synthesis. Molec. Pharmacol. 3, 549–555 (1967).
Spector, S., Gordon, R., Sjoerdsma, A., Udenfriend, S., Sjoerdsma, A., Udenfriend, S.: Blockade of endogenous norepinephrine synthesis by α-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol, exp. Ther. 147, 86–95 (1965).
Suärne, L., Lishajko, F.: Localization of different steps in noradrenaline synthesis to different fractions of a bovine splenic nerve homogenate. Biochem. Pharmacol. 16, 1719–1728 (1967).
Stone, C.A., Porter, C.C.: Biochemistry and pharmacology of methyldopa and some related structures. Advanc. Drug Res. 4, 71–93 (1967).
Stone, C.A., Porter, C.C., Ross, C.A., Wenger, H.C., Ludden, C.T., Blessing, J. A., Totaro, J. A., Porter, C.C.: Effects of α-methyl–3, 4-dihydroxyphenylalanine (Methyldopa), reserpine and related agents on some vascular responses in the dog. J. Pharmacol, exp. Ther. 136, 80–88 (1962).
Stone, C.A., Porter, C.C., Ross, C.A., Wenger, H.C., Ludden, C.T., Blessing, J. A., Totaro, J. A., Porter, C.C., Stavorski, J.M., Ludden, C.T., Wenger, H.C., Ross, C. A., Totaro, J. A., Porter, C.C.: Comparison of some pharmacological effects of certain 6-substituted dopamine derivatives with reserpine, guanethidine and metaraminol. J. Pharmacol, exp. Ther. 142, 147–156 (1963).
Stott, A.W., Robinson, R.: Urinary phenols in patients treated with α-methyldopa. J. Pharm. Pharmacol. 15, 773–774 (1963).
Stott, A.W., Robinson, R.: The effects of α-methyldopa on excretion of noradrenaline metabolites. J. Pharm.Pharmacol. 19, 690–693 (1967).
Sugarman, S.R., Margolius, H.S., Gaffney, T.E., Mohammed, S.: Effect of methyldopa on chronotropic responses to cardioaccelerator nerve stimulation in dogs. J. Pharmacol, exp. Ther. 162, 115–120 (1968).
Sugrije, M.F., Shore, P.A.: The mode of sodium dependency of the adrenergic neuron amine carrier. Evidence for a second, sodium-dependent, optically specific and reserpine-sensitive system. J. Pharmacol, exp. Ther. 170, 239–245 (1969).
Swamy, V.C., Tye, A., La Pidijs, J.B., Patil, P.N.: Steric aspects of adrenergic drugs. XIII. Norepinephrine potentiating effects of isomers of sympathomimetic amine in rat vas deferens and atria. Arch. int. Pharmacodyn. 182, 24–31 (1969).
Thoa, N.B., Eccleston, D., Axelrod, J.: The accumulation of C14-serotonin in the guinea-pig vas deferens. J. Pharmacol, exp. Ther. 169, 68–73 (1969).
Thoenen, H.: Bildung und funktionelle Bedeutung adrenerger Ersatztransmitter. Berlin-Heidelberg-New York: Springer 1969.
Thoenen, H., Haefely, W., Gey, K.E., Hürlimann, A.: Diminished effects of sympathetic nerve stimulation in cats pretreated with disulfiram; liberation of dopamine as sympathetic transmitter. Life Sci. 4, 2033–2038 (1965).
Thoenen, H., Haefely, W., Gey, K.E., Hürlimann, A.: The effect of α-methyl-tyrosine on peripheral sympathetic transmission. Life Sci. 5, 723–730 (1966a).
Thoenen, H., Haefely, W., Gey, K.E., Hürlimann, A.: Quantitative aspects of the replacement of norepinephrine by dopamine as asympathetic transmitter after inhibition of dopamine-ß-hydroxylase by disulfiram. J. Pharmacol, exp. Ther. 156, 246–251 (1967 a).
Thoenen, H., Haefely, W., Gey, K.E., Hürlimann, A.: Liberation of α-methyldopamine as a “false” sympathetic transmitter afterpretreatment of cats with α-methyldopa and disulfiram. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 258, 181–196 (1967b).
Thoenen, H., Haefely, W., Gey, K.E., Hürlimann, A.: Diminished effect of sympathetic nerve stimulation in cats pretreated with5-hydroxydopa; formation and liberation of false adrenergic transmitters. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 259, 17–33 (1967 c).
Thoenen, H., Haefely, W., Gey, K.E., Hürlimann, A., Häusler, G., Hürlimann, A.: Formation of a “false” adrenergic transmitter in catspretreated with 4-methoxy–3, 5-dihydroxyphenylalanine and its effects on postganglionic transmission. J. Pharmacol, exp. Ther. 162, 70–79 (1968).
Thoenen, H., Haefely, W., Gey, K.E., Hürlimann, A., Häusler, G., Hürlimann, A., Hürlimann, A., Gey, K.F., Haefely, W.: Liberation of p-hydroxynorephedrine from cat spleen by sympathetic nerve stimulation after pretreatment with amphetamine. Life Sci. 5, 1715–1722 (1966b).
Thoenen, H., Haefely, W., Gey, K.E., Hürlimann, A., Häusler, G., Hürlimann, A., Hürlimann, A., Gey, K.F., Haefely, W., Haefely, W.: The effect of sympathetic nerve stimulation on volume, vascularresistance, and norepinephrine output in the isolated perfused spleen of the cat, and its modification by cocaine. J. Pharmacol, exp. Ther. 143, 57–63 (1964).
Thoenen, H., Haefely, W., Gey, K.E., Hürlimann, A., Häusler, G., Hürlimann.: Functional importance of subcellular distribution of false adrenergic transmitters. Progr. Brain Res. in the press (1971).
Torchiana, M.L., Porter, C.C., Stone, C.A.: Relation between molecular configuration and certain biological actions of α-methyldopamine and α-methyl-meta-tyramine and their /Miydroxylated products α-methylnorepinephrine and metaraminol. Arch. int. Pharmacodyn. 174, 118–134 (1968).
Torchiana, M.L., Porter, C.C., Stone, C.A., Hanson, H.M.: Some biochemical and pharmacological actions of α-methylphenyl-alanine. Biochem. Pharmacol. 19, 1601–1614 (1970).
Torchiana, M.L., Porter, C.C., Stone, C.A., Hanson, H.M., Wenger, H.C., Stavorski, J., Ludden, C.T., Stone, C.A.: Effect of methyldopa and related agents on pressor responses to tyramine in reserpine-pretreated rats and dogs. J. Pharmacol, exp. Ther. 151, 242–252 (1966).
Trendelenburg, U.: The effect of sympathetic nerve stimulation on isolated atria of guinea pigs and rabbits pretreated with reserpine. J. Pharmacol, exp. Ther. 147, 313–318 (1965).
Trendelenburg, U., Muskus, A., Fleming, W. W., Gomez Alonso De La Sierra, G.: Modification by reserpine of the action of sympathomimetic amines in spinal cats; a classification of sympathomimetic amines. J. Pharmacol, exp. Ther. 138, 170–180 (1962).
Trinker, F.R.: The significance of the relative potencies of noradrenaline and α-methylnor-adrenaline for the mode of action of α-methyldopa. J. Pharm. Pharmacol. 23, 306–308 (1971).
Udenfriend, S.: Physiological regulation of noradrenaline biosynthesis. In: Adrenergic Neurotransmission. Eds. Wolstenholme, G.E.W., O’Connor, M. 3–11. London: J. & A. Churchill 1968.
Udenfriend, S., Zaltzman-Nirenberg, P.: On the mechanism of the norepinephrine release produced by α-methyl-meta-tyrosine. J. Pharmacol, exp. Ther. 138, 194–199 (1962).
Udenfriend, S., Zaltzman-Nirenberg, P., Gordon, K., Spector, S.: Evaluation of the biochemical effects produced in vivo byinhibitors of the three enzymes involved in norepinephrine biosynthesis. Molec. Pharmacol. 2, 95–105 (1966).
Udenfriend, S., Zaltzman-Nirenberg, P., Gordon, K., Spector, S., Nagatsu, T.: Inhibitors of purified beef adrenal tyrosine hydroxylase. Biochem.Pharmacol. 14, 837–845 (1965).
Van Orden, L.S., Bensch, K.G., Giarman, N.J.: Histochemical and functional relationships of catecholamines in adrenergic nerve endings. II. Extravesicular norepinephrine. J. Pharmacol, exp. Ther. 155, 428–439 (1967).
Varma, D.H., Benfey, B.G.: Antagonism of reserpine-induced subsensitivity to tyramine by α-methyldopa. J. Pharmacol, exp. Ther. 141, 310–313 (1963).
Waldeck, B.: On the interaction of threo–3H-a-methylnoradrenaline with the uptake and storage mechanisms of the adrenergic neuron. Europ. J. Pharmacol. 2, 208–213 (1967).
Waldeck, B.: On the stereospecificity of the ß-hydroxylation of α-methyldopamine. Europ. J. Pharmacol. 5, 114–116 (1968).
Waldeck, B.: Failure to demonstrate monoamine oxidase inhibition by glyceryl trinitrate in vivo. Acta Pharmacol. (Kbh.) 28, 406–412 (1970).
Weber, E., Muscholl, E.: Der Einfluß verschiedener Pharmaka auf die Elimination von α-Methylnoradrenalin aus der Perfusionsflüssigkeit des isolierten Kaninchenherzens. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 251, 161–162 (1965).
Weber, L.J.: Drug interactions between disulfiram and α-methyldopa and related agents in reserpine-pretreated rats. Proc. Soc. exp. Biol. (N.Y.) 123, 349–352 (1966).
Weiner, N., Selvaratnam, I.: The effect of tyramine on the synthesis of norepinephrine. J. Pharmacol, exp. Ther. 161, 21–33 (1968).
Weissbach, H., Lovenberg, W., Udenfriend, S.: Enzymatic decarboxylation of α-methyl amino acids. Biochem. biophys. Res. Commun. 3, 225–227 (1960).
Werle, E., Sell, J.: Über die fermentative Decarboxylierung von Mono-und Dioxyphenyl-serinen. Biochem. Z. 326, 110–122 (1954).
Young, J. A., Edwards, K.D.G.: Studies on the absorption, metabolism and excretion of methyldopa and other catechols and their influence on amino acid transport in rats. J. Pharmacol, exp. Ther. 145, 102–112 (1964).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Muscholl, E. (1972). Adrenergic False Transmitters. In: Blaschko, H., Muscholl, E. (eds) Catecholamines. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65249-3_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-65249-3_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65251-6
Online ISBN: 978-3-642-65249-3
eBook Packages: Springer Book Archive